These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

251 related articles for article (PubMed ID: 31769533)

  • 1. Masked bolus gluten challenge low in FODMAPs implicates nausea and vomiting as key symptoms associated with immune activation in treated coeliac disease.
    Daveson AJM; Tye-Din JA; Goel G; Goldstein KE; Hand HL; Neff KM; Williams LJ; Truitt KE; Anderson RP;
    Aliment Pharmacol Ther; 2020 Jan; 51(2):244-252. PubMed ID: 31769533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated serum interleukin-2 after gluten correlates with symptoms and is a potential diagnostic biomarker for coeliac disease.
    Tye-Din JA; Daveson AJM; Ee HC; Goel G; MacDougall J; Acaster S; Goldstein KE; Dzuris JL; Neff KM; Truitt KE; Anderson RP
    Aliment Pharmacol Ther; 2019 Oct; 50(8):901-910. PubMed ID: 31483515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of gluten peptide-based antigen-specific immunotherapy (Nexvax2) in adults with coeliac disease after bolus exposure to gluten (RESET CeD): an interim analysis of a terminated randomised, double-blind, placebo-controlled phase 2 study.
    Tye-Din JA; Daveson AJM; Goel G; Goldstein KE; Hand HL; Neff KM; Popp A; Taavela J; Maki M; Isola J; Williams LJ; Truitt KE; Anderson RP;
    Lancet Gastroenterol Hepatol; 2023 May; 8(5):446-457. PubMed ID: 36898393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patient factors influencing acute gluten reactions and cytokine release in treated coeliac disease.
    Tye-Din JA; Daveson AJM; Goldstein KE; Hand HL; Neff KM; Goel G; Williams LJ; Truitt KE; Anderson RP;
    BMC Med; 2020 Nov; 18(1):362. PubMed ID: 33239013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of vomiting and nausea and associated factors after chronic and acute gluten exposure in celiac disease.
    Ahonen I; Laurikka P; Koskimaa S; Huhtala H; Lindfors K; Kaukinen K; Kurppa K; Kivelä L
    BMC Gastroenterol; 2023 Sep; 23(1):301. PubMed ID: 37674120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety and efficacy of AMG 714 in adults with coeliac disease exposed to gluten challenge: a phase 2a, randomised, double-blind, placebo-controlled study.
    Lähdeaho ML; Scheinin M; Vuotikka P; Taavela J; Popp A; Laukkarinen J; Koffert J; Koivurova OP; Pesu M; Kivelä L; Lovró Z; Keisala J; Isola J; Parnes JR; Leon F; Mäki M
    Lancet Gastroenterol Hepatol; 2019 Dec; 4(12):948-959. PubMed ID: 31494096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-coeliac gluten or wheat sensitivity: emerging disease or misdiagnosis?
    Potter M; Walker MM; Talley NJ
    Med J Aust; 2017 Aug; 207(5):211-215. PubMed ID: 28987135
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of expectancy versus actual gluten intake on gastrointestinal and extra-intestinal symptoms in non-coeliac gluten sensitivity: a randomised, double-blind, placebo-controlled, international, multicentre study.
    de Graaf MCG; Lawton CL; Croden F; Smolinska A; Winkens B; Hesselink MAM; van Rooy G; Weegels PL; Shewry PR; Houghton LA; Witteman BJM; Keszthelyi D; Brouns FJPH; Dye L; Jonkers DMAE
    Lancet Gastroenterol Hepatol; 2024 Feb; 9(2):110-123. PubMed ID: 38040019
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Plasma IL-2 and Symptoms Response after Acute Gluten Exposure in Subjects With Celiac Disease or Nonceliac Gluten Sensitivity.
    Cartee AK; Choung RS; King KS; Wang S; Dzuris JL; Anderson RP; Van Dyke CT; Hinson CA; Marietta E; Katzka DA; Nehra V; Grover M; Murray JA
    Am J Gastroenterol; 2022 Feb; 117(2):319-326. PubMed ID: 34797778
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytokine release and gastrointestinal symptoms after gluten challenge in celiac disease.
    Goel G; Tye-Din JA; Qiao SW; Russell AK; Mayassi T; Ciszewski C; Sarna VK; Wang S; Goldstein KE; Dzuris JL; Williams LJ; Xavier RJ; Lundin KEA; Jabri B; Sollid LM; Anderson RP
    Sci Adv; 2019 Aug; 5(8):eaaw7756. PubMed ID: 31457091
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-coeliac gluten sensitivity and the spectrum of gluten-related disorders: an updated overview.
    Dale HF; Biesiekierski JR; Lied GA
    Nutr Res Rev; 2019 Jun; 32(1):28-37. PubMed ID: 30009718
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Larazotide acetate in patients with coeliac disease undergoing a gluten challenge: a randomised placebo-controlled study.
    Kelly CP; Green PH; Murray JA; Dimarino A; Colatrella A; Leffler DA; Alexander T; Arsenescu R; Leon F; Jiang JG; Arterburn LA; Paterson BM; Fedorak RN;
    Aliment Pharmacol Ther; 2013 Jan; 37(2):252-62. PubMed ID: 23163616
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sensitivity to wheat, gluten and FODMAPs in IBS: facts or fiction?
    De Giorgio R; Volta U; Gibson PR
    Gut; 2016 Jan; 65(1):169-78. PubMed ID: 26078292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine release after gluten ingestion differentiates coeliac disease from self-reported gluten sensitivity.
    Tye-Din JA; Skodje GI; Sarna VK; Dzuris JL; Russell AK; Goel G; Wang S; Goldstein KE; Williams LJ; Sollid LM; Lundin KE; Anderson RP
    United European Gastroenterol J; 2020 Feb; 8(1):108-118. PubMed ID: 32213060
    [TBL] [Abstract][Full Text] [Related]  

  • 15. No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates.
    Biesiekierski JR; Peters SL; Newnham ED; Rosella O; Muir JG; Gibson PR
    Gastroenterology; 2013 Aug; 145(2):320-8.e1-3. PubMed ID: 23648697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fructan, Rather Than Gluten, Induces Symptoms in Patients With Self-Reported Non-Celiac Gluten Sensitivity.
    Skodje GI; Sarna VK; Minelle IH; Rolfsen KL; Muir JG; Gibson PR; Veierød MB; Henriksen C; Lundin KEA
    Gastroenterology; 2018 Feb; 154(3):529-539.e2. PubMed ID: 29102613
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wheat Sensitivity and Functional Dyspepsia: A Pilot, Double-Blind, Randomized, Placebo-Controlled Dietary Crossover Trial with Novel Challenge Protocol.
    Potter MDE; Duncanson K; Jones MP; Walker MM; Keely S; Talley NJ
    Nutrients; 2020 Jun; 12(7):. PubMed ID: 32629906
    [No Abstract]   [Full Text] [Related]  

  • 18. Dietary analysis in symptomatic patients with coeliac disease on a gluten-free diet: the role of trace amounts of gluten and non-gluten food intolerances.
    Faulkner-Hogg KB; Selby WS; Loblay RH
    Scand J Gastroenterol; 1999 Aug; 34(8):784-9. PubMed ID: 10499479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Symptomatic suspected gluten exposure is common among patients with coeliac disease on a gluten-free diet.
    Silvester JA; Graff LA; Rigaux L; Walker JR; Duerksen DR
    Aliment Pharmacol Ther; 2016 Sep; 44(6):612-9. PubMed ID: 27443825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wheat challenge in self-reported gluten sensitivity: a comparison of scoring methods.
    Skodje GI; Henriksen C; Salte T; Drivenes T; Toleikyte I; Lovik AM; Veierød MB; Lundin KE
    Scand J Gastroenterol; 2017 Feb; 52(2):185-192. PubMed ID: 27797273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.